< Return to Video

Dr. Melanie Swift: COVID-19 vaccine urgency as delta variant continues to spread

  • 0:00 - 0:03
    we really need to take advantage of this
  • 0:03 - 0:04
    time right now
  • 0:04 - 0:06
    when we have the vaccines they are
  • 0:06 - 0:07
    freely available
  • 0:07 - 0:10
    for everyone to get vaccinated so that
  • 0:10 - 0:11
    we can stop
  • 0:11 - 0:15
    the spread of the delta variant but also
  • 0:15 - 0:18
    we can prevent the development of
  • 0:18 - 0:21
    new variants the situation with the
  • 0:21 - 0:23
    delta variant
  • 0:23 - 0:25
    can't really be understated at this
  • 0:25 - 0:28
    point we are really at a pivotal moment
  • 0:28 - 0:31
    in the pandemic right now we were on the
  • 0:31 - 0:32
    down
  • 0:32 - 0:33
    trend in the united states with
  • 0:33 - 0:35
    increasing vaccination rates and
  • 0:35 - 0:37
    decreasing cases
  • 0:37 - 0:41
    new cases and what has happened is that
  • 0:41 - 0:42
    we've gone from having our first
  • 0:42 - 0:44
    case of the delta variant in the united
  • 0:44 - 0:46
    states in march
  • 0:46 - 0:49
    to it now being the vast majority of our
  • 0:49 - 0:51
    sequenced
  • 0:51 - 0:55
    cases the delta variant which was
  • 0:55 - 0:58
    first seen in december in india is more
  • 0:58 - 1:00
    contagious
  • 1:00 - 1:03
    than the previous strains that we've had
  • 1:03 - 1:05
    in the united states
  • 1:05 - 1:07
    but it's also causing more severe
  • 1:07 - 1:09
    illness
  • 1:09 - 1:13
    so that is causing hospitalizations
  • 1:13 - 1:17
    to increase icu admissions to increase
  • 1:17 - 1:22
    and we're looking at another wave
  • 1:22 - 1:26
    of the pandemic so it's more contagious
  • 1:26 - 1:29
    and that's concerning it's more serious
  • 1:29 - 1:31
    and that's concerning
  • 1:31 - 1:34
    the messenger rna vaccines are highly
  • 1:34 - 1:35
    effective
  • 1:35 - 1:37
    against this variant so we have that
  • 1:37 - 1:39
    information from clinical studies
  • 1:39 - 1:43
    as well as from laboratory tests of
  • 1:43 - 1:45
    what we think the immune response should
  • 1:45 - 1:47
    be and so they're showing
  • 1:47 - 1:50
    clinically in the in the uk where the
  • 1:50 - 1:51
    delta variant
  • 1:51 - 1:55
    has been taking hold for many months now
  • 1:55 - 1:58
    that those mrna vaccines are still
  • 1:58 - 2:00
    highly effective
  • 2:00 - 2:03
    so over 80 percent for infection and
  • 2:03 - 2:06
    90 or so for severe disease
  • 2:06 - 2:08
    so it's still very important to take
  • 2:08 - 2:09
    those vaccines
  • 2:09 - 2:11
    the johnson and johnson vaccine is
  • 2:11 - 2:14
    probably also going to be very effective
  • 2:14 - 2:17
    there are some early studies looking at
  • 2:17 - 2:20
    the laboratory measurement
  • 2:20 - 2:22
    of our immune system response that are
  • 2:22 - 2:24
    very promising and show really good
  • 2:24 - 2:25
    response
  • 2:25 - 2:28
    to the delta variant but we don't yet
  • 2:28 - 2:32
    have large numbers of people in clinical
  • 2:32 - 2:33
    studies
  • 2:33 - 2:36
    to see what the impact of the johnson
  • 2:36 - 2:38
    johnson vaccine is on the delta variant
  • 2:38 - 2:39
    just yet
  • 2:39 - 2:41
    but we're very hopeful that that's going
  • 2:41 - 2:43
    to be positive as well
  • 2:43 - 2:46
    we want everyone who is able to get
  • 2:46 - 2:48
    vaccinated to get vaccinated
  • 2:48 - 2:50
    you know we've sort of stalled out in
  • 2:50 - 2:52
    the united states with our vaccination
  • 2:52 - 2:54
    rates
  • 2:54 - 2:56
    and nationally only half of the
  • 2:56 - 2:57
    population
  • 2:57 - 3:00
    has been fully documented a little less
  • 3:00 - 3:02
    than half
  • 3:02 - 3:04
    and there are some states that are doing
  • 3:04 - 3:05
    better and some states that are lagging
  • 3:05 - 3:06
    behind
  • 3:06 - 3:08
    and we're seeing that those states that
  • 3:08 - 3:11
    have lower vaccination rates
  • 3:11 - 3:13
    is where the delta variant is spreading
  • 3:13 - 3:14
    the most
  • 3:14 - 3:18
    people have often been waiting to see
  • 3:18 - 3:20
    how people respond to the vaccines and
  • 3:20 - 3:22
    what kind of side effects happen
  • 3:22 - 3:25
    if people have been waiting to see now's
  • 3:25 - 3:27
    your chance to go ahead and get
  • 3:27 - 3:28
    vaccinated because you've
  • 3:28 - 3:31
    we've seen that people do very very well
  • 3:31 - 3:33
    side effects are mild they're
  • 3:33 - 3:35
    self-limited these vaccines are
  • 3:35 - 3:35
    incredibly
  • 3:35 - 3:39
    safe now is the time for people to get
  • 3:39 - 3:40
    vaccinated
  • 3:40 - 3:42
    that's really the only way that we're
  • 3:42 - 3:43
    going to stave
  • 3:43 - 3:46
    off what could be a really devastating
  • 3:46 - 3:47
    next wave
  • 3:47 - 3:50
    of this pandemic there have been a
  • 3:50 - 3:53
    couple of more serious adverse events
  • 3:53 - 3:54
    that were so rare
  • 3:54 - 3:57
    that they didn't occur in those large
  • 3:57 - 3:59
    clinical trials of more than 40
  • 3:59 - 4:02
    000 people so when we're talking about
  • 4:02 - 4:03
    things that are so rare
  • 4:03 - 4:06
    it's a few in a million you can't detect
  • 4:06 - 4:07
    those
  • 4:07 - 4:10
    even in very large clinical trials so
  • 4:10 - 4:11
    what we
  • 4:11 - 4:14
    have done is we have these really robust
  • 4:14 - 4:17
    surveillance systems to detect more rare
  • 4:17 - 4:18
    problems
  • 4:18 - 4:21
    and we have detected a few of those now
  • 4:21 - 4:24
    the first one was the bleeding and
  • 4:24 - 4:25
    clotting problem
  • 4:25 - 4:27
    that was associated with the johnson
  • 4:27 - 4:28
    johnson
  • 4:28 - 4:33
    vaccine which is also seen with other
  • 4:33 - 4:35
    vaccines in that same platform the
  • 4:35 - 4:37
    astrozenica vaccine
  • 4:37 - 4:41
    and that primarily affects women under
  • 4:41 - 4:44
    50. and it's still incredibly rare
  • 4:44 - 4:48
    and it is still safe for women to take
  • 4:48 - 4:52
    either kind of vaccine the second
  • 4:52 - 4:54
    condition that we found through this
  • 4:54 - 4:56
    vaccine surveillance system
  • 4:56 - 5:00
    is myocarditis which is associated with
  • 5:00 - 5:00
    the
  • 5:00 - 5:04
    mrna vaccines in predominantly
  • 5:04 - 5:08
    males and it appears to be more common
  • 5:08 - 5:09
    in younger males
  • 5:09 - 5:13
    but adults including older adults have
  • 5:13 - 5:16
    also experienced it
  • 5:16 - 5:19
    and myocarditis is an inflammation of
  • 5:19 - 5:20
    the heart
  • 5:20 - 5:23
    and it's really rare people don't often
  • 5:23 - 5:24
    talk about it or know about
  • 5:24 - 5:26
    it but it actually is a complication of
  • 5:26 - 5:28
    covet infection
  • 5:28 - 5:30
    it's also a complication of other viral
  • 5:30 - 5:32
    infections
  • 5:32 - 5:34
    and when people have this they often
  • 5:34 - 5:36
    don't know the cause of it
  • 5:36 - 5:39
    but unlike those clotting and bleeding
  • 5:39 - 5:39
    disorder
  • 5:39 - 5:42
    that was found in women associated with
  • 5:42 - 5:44
    the johnson johnson vaccine
  • 5:44 - 5:46
    this is a condition that's pretty
  • 5:46 - 5:48
    straightforward to identify
  • 5:48 - 5:51
    standard treatment is conservative care
  • 5:51 - 5:53
    with some medications like
  • 5:53 - 5:55
    anti-inflammatory medications
  • 5:55 - 5:59
    and people do very well
  • 5:59 - 6:02
    and go home from the hospital and and
  • 6:02 - 6:06
    recover fully i would say it is still
  • 6:06 - 6:10
    safe and recommended for everyone to be
  • 6:10 - 6:11
    vaccinated
  • 6:11 - 6:14
    even with these rare conditions that
  • 6:14 - 6:16
    have been found to be associated with
  • 6:16 - 6:18
    the vaccines
  • 6:18 - 6:21
    because the risks are far outweighed by
  • 6:21 - 6:23
    the benefits of vaccination
  • 6:23 - 6:26
    we have not seen any concerns for
  • 6:26 - 6:29
    reproductive side effects from any of
  • 6:29 - 6:31
    the covet vaccines and that
  • 6:31 - 6:34
    includes fertility as well as birth
  • 6:34 - 6:36
    outcomes
  • 6:36 - 6:39
    these concerns arose out of an internet
  • 6:39 - 6:40
    rumor
  • 6:40 - 6:43
    which is actually a complete fabrication
  • 6:43 - 6:47
    there is no concern for
  • 6:47 - 6:50
    safety of women who are pregnant women
  • 6:50 - 6:51
    who are trying to conceive
  • 6:51 - 6:56
    or for future reproductive development
Title:
Dr. Melanie Swift: COVID-19 vaccine urgency as delta variant continues to spread
Description:

more » « less
Video Language:
English
Team:
Amplifying Voices
Project:
COVID-19 Pandemic
Duration:
06:55

English subtitles

Revisions Compare revisions